Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Provexis plc

Market Cap 25.22M 33.89M 29.21M 26.88M 47.37M 3.2B 47.84M 318M 124M 1.57B 127M 124M 5.43B P/E Ratio 2024
-20.9x
P/E Ratio 2025 -22.6x
Enterprise Value 24.51M 32.94M 28.39M 26.13M 46.04M 3.11B 46.5M 309M 121M 1.52B 124M 121M 5.27B EV / Sales 2024
17x
EV / Sales 2025 7.62x
Free-Float
79.97%
Yield 2024 *
-
Yield 2025 -
1 day+4.27%
1 week+3.27%
Current month+2.29%
1 month+13.05%
3 months+7.40%
6 months+63.97%
Current year+19.33%
1 week 0.8
Extreme 0.8028
1.1
1 month 0.8
Extreme 0.8
1.12
Current year 0.77
Extreme 0.77
1.55
1 year 0.55
Extreme 0.55
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer 52 1999-12-31
Director TitleAgeSince
Director/Board Member - 2010-11-10
Chairman 79 2005-05-31
Director/Board Member 52 2019-04-11
Date Insider Type Main position Quantity % Market Cap.
25-01-06Free

Chief Executive Officer

30,000,000 1.2788%
23-01-23Free

Chief Executive Officer

17,000,000 0.7665%
23-01-23Free

Chief Technology Officer

17,000,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
+4.27%+3.27%+67.81%+85.17% 32.47M
+0.50%-1.98%+37.64%+95.22% 13.72B
+6.50%+4.83%-58.02%+134.69% 5.09B
+1.31%+6.60%-10.77%-57.72% 2.48B
+0.30%-2.13% - - 1.58B
+0.91%-0.62%-20.14%-25.58% 1.3B
+0.54%+7.43%+50.43%-2.49% 1.24B
0.00%+0.56%-62.06%-66.24% 1.13B
+0.08%+1.92%+1.41%+23.61% 1.09B
-3.95%+2.61%-86.23%-75.95% 1.03B
Average +1.04%+2.68%-8.88%+12.30% 2.87B
Weighted average by Cap. +1.45%+1.06%+2.78%+62.25%

Financials

2024 2025
Net sales 802K 1.08M 929K 855K 1.51M 102M 1.52M 10.11M 3.95M 49.88M 4.04M 3.96M 173M 1.29M 1.74M 1.5M 1.38M 2.43M 164M 2.45M 16.28M 6.36M 80.37M 6.52M 6.38M 278M
Net income -586K -788K -679K -625K -1.1M -74.45M -1.11M -7.39M -2.89M -36.46M -2.96M -2.89M -126M -453K -608K -524K -483K -850K -57.5M -859K -5.71M -2.23M -28.16M -2.28M -2.23M -97.43M
Net Debt -189K -254K -219K -202K -356K -24.05M -359K -2.39M -932K -11.78M -955K -935K -40.75M -708K -952K -820K -755K -1.33M -89.93M -1.34M -8.92M -3.49M -44.04M -3.57M -3.5M -152M
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
26-06-16 1.074 p +4.27% 3,284,486
26-06-15 1.030 p +9.57% 165,325
26-06-12 0.9400 p -6.93% 537,219
26-06-11 1.010 p +7.45% 590,193
26-06-10 0.9400 p -9.62% 152,227
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!